Highly Defined Induced Pluripotent Stem Cell Lines Mimic Donor Red Blood Cell Antigen Profiles for Therapeutic and Diagnostic Use
- PMID: 38917437
- DOI: 10.1089/cell.2024.0018
Highly Defined Induced Pluripotent Stem Cell Lines Mimic Donor Red Blood Cell Antigen Profiles for Therapeutic and Diagnostic Use
Abstract
Our group generated two induced pluripotent stem cell (iPSC) lines for in vitro red blood cell (RBC) production from blood donors with extensively known erythrocyte antigen profiles. One line was intended to give rise to RBCs for transfusions in patients with sickle cell disease (SCD), while the other was developed to create RBC panel reagents. Two blood donors were selected based on their RBC phenotypes, further complemented by high-throughput DNA array analysis to obtain a more comprehensive erythrocyte antigen profile. Enriched erythroblast populations from the donors' peripheral blood mononuclear cells were reprogrammed into iPSCs using nonintegrative plasmid vectors. The iPSC lines were characterized and subsequently subjected to hematopoietic differentiation. iPSC PB02 and iPSC PB12 demonstrated in vitro and in vivo iPSC features and retained the genotype of each blood donor's RBC antigen profile. Colony-forming cell assays confirmed that iPSC PB02 and iPSC PB12 generated hematopoietic progenitors. These two iPSC lines were generated with defined erythrocyte antigen profiles, self-renewal capacity, and hematopoietic differentiation potential. With improvements in hematopoietic differentiation, these cells could potentially be more efficiently differentiated into RBCs in the future. They could serve as a complementary approach for obtaining donor-independent RBCs and addressing specific demands for blood transfusions.
Keywords: RBC antigens; blood transfusion; induced pluripotent stem cells (iPSCs); reagent RBC manufacture; red blood cells (RBCs); sickle cell disease (SCD).
Similar articles
-
Generation of red blood cells from induced pluripotent stem cells.Curr Opin Hematol. 2024 May 1;31(3):115-121. doi: 10.1097/MOH.0000000000000810. Epub 2024 Feb 13. Curr Opin Hematol. 2024. PMID: 38362913 Review.
-
Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice.Am J Hematol. 2022 Feb 1;97(2):194-202. doi: 10.1002/ajh.26410. Epub 2021 Nov 24. Am J Hematol. 2022. PMID: 34779029 Free PMC article.
-
Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.Biomolecules. 2021 Jun 30;11(7):963. doi: 10.3390/biom11070963. Biomolecules. 2021. PMID: 34208829 Free PMC article.
-
Differentiation of human induced pluripotent stem cells into erythroid cells.Stem Cell Res Ther. 2020 Nov 16;11(1):483. doi: 10.1186/s13287-020-01998-9. Stem Cell Res Ther. 2020. PMID: 33198819 Free PMC article. Review.
-
Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes.J Transl Med. 2020 Jun 12;18(1):236. doi: 10.1186/s12967-020-02403-y. J Transl Med. 2020. PMID: 32532292 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical